Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy:consensus proposal by the ad hoc Task Force of the ILAE Commission on therapeutic strategies[J]. Epilepsia, 2010, 51(6):1069-1077.
[2]
Picot MC, Baldy-Moulinier M, Daurès JP, et al. The prevalence of epilepsy and pharmacoresistant epilepsy in adults:a population-based study in a estern European country[J]. Epilepsia, 2008, 49(7):1230-1238.
[3]
Gilgenkrantz S, Cabrol C, Lausecker C, et al. The Dr syndrome. Study of a further case (46, XX, 14r)[J]. Ann Genet, 1971, 14(1):23-31.
Giovannini S, Marangio L, Fusco C, et al. Epilepsy in ring 14 syndrome:a clinical and EEG study of 22 patients[J]. Epilepsia, 2013, 54(12):2204-2213.
[6]
Ville D, DE Bellescize J, Nguyen MA, et al. Ring 14 chromosome presenting as early-onset isolated partial epilepsy[J]. Dev Med Child Neurol, 2009, 51(11):917-922.
[7]
Zollino M, Ponzi E, Gobbi G, et al. The ring 14 syndrome[J]. Eur J Med Genet, 2012, 55(5):374-380.
[8]
Zampini L, Zanchi P, D'Odorico L. Developing with ring 14 syndrome:A survey in different countries[J]. Clin Linguist Phon, 2014, 28(11):844-856.
[9]
Guilherme RS, de Freitas Ayres Meloni V, Sodré CP, et al. Cytogenetic and molecular evaluation and 20-year follow-up of a patient with ring chromosome 14[J]. Am J Med Genet A, 2010, 152A(11):2865-2869.
[10]
Guilherme RS, Moysés-Oliveira M, Dantas AG, et al. Position effect modifying gene expression in a patient with ring chromosome 14[J]. J Appl Genet, 2016, 57(2):183-187.
[11]
Zollino M, Seminara L, Orteschi D, et al. The ring 14 syndrome:clinical and molecular definition[J]. Am J Med Genet A, 2009, 149A(6):1116-1124.
[12]
Chung I, Chawla R, FitzGerald DE. Ocular manifestations of chromosome 14 terminal deletion[J]. J Pediatr Ophthalmol Strabismus, 2006, 43(2):104-106.